Diastolic Ventricular Interaction and the Effects of Biventricular Pacing in Hypertrophic Cardiomyopathy

Status

UNKNOWN

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00698074

Enrollment

Registered

2008-06-16

Start date

Unknown

Completion date

Unknown

Last updated

2008-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic Cardiomyopathy

Brief summary

The primary aim of this study will be to assess whether Biventricular pacing improves exercise capacity, and Quality of Life in patients with symptomatic drug resistant Non-Obstructive Hypertrophic Cardiomyopathy, using a Biventricular pacemaker.

Interventions

DEVICECardiac Resynchronisation Therapy

Biventricular Pacemaker Implant

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Symptomatic Hypertrophic Cardiomyopathy,

Exclusion criteria

* Rhythm other than normal sinus Left ventricular outflow tract gradient greater than 30mmHg Inability to exercise v02 max greater than 70% of predicted.

Countries

United Kingdom

Contacts

Primary ContactMichael P Frenneaux, MBBS

m.p.frenneaux@bham.ac.uk121-414-5916

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026